What move does the options market price into Compass Therapeutics's report?

Implied ±31.0%, either direction.

How often does Compass Therapeutics move more than the options market prices?

0 of the last 7 reports moved at least as far as the implied move.

CMPXNasdaqBiological Products, (No Diagnostic Substances)

Compass Therapeutics, Inc. (CMPX) earnings date, market-implied expected move, and options open interest by expiry

0.77

+0.01 · +1.73%

post 0.77 0.00%

After hours16:00 ET

Open0.78Volume1.6MMkt cap$135.6MEPS-0.39

Day0.76 – 0.7813%52-wk0.73 – 6.881%

CMPX

Compass Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±31.0%implied · straddle

0.520.99

spot 0.75exp Nov 20ATM strike 1ATM straddle 0.28IV 94%

Nov 3 close

Expected move

Inputs

Next report

Today

before open

est.Q3 FY26

Calendar

Next report

Last report

+5.29%

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

13F top-10 QoQ

+14.17%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

215 managers

Top fund weight

0.14%

CMPX weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Compass Therapeutics (CMPX) is expected to report on Nov 4 before open (estimated date).

Implied vs realized

8 reports

0 of 7≥ implied

avg implied: ±36.8%
avg realized: ±4.6%

Feb 27 '25Feb 27 '25confirmed±52.2%▼−1.68%×0.03

May 8 '25May 8 '25confirmed±57.9%▲+1.14%×0.02

Aug 11 '25Aug 11 '25confirmed±32.7%▲+23.70%×0.72

Q3 FY25Nov 5 '25confirmed±13.1%▲+0.79%×0.06

Jan 6 '26Jan 6 '26confirmed±33.6%▼−1.60%×0.05

Q1 FY26Mar 5 '26confirmed±52.0%▼−2.81%×0.05

May 5 '26May 5 '26confirmed±16.1%▲+0.52%×0.03

Q2 FY26Aug 6 '26confirmed—▲+5.29%—

quarterimplied−60%0+60%realized×

Q2 FY26—▲+5.29%—

May '26±16.1%+0.52%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 3 close

0.03OI · 4 expiries · Nov 3 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

1,471−7%Nov 2016d42,7360%

4800%Dec 1844d0.133,725+1%0.13

61,0560%Jan 1572d3.5617,1570%3.56

150%Feb 19107d0.029240%0.02

ExpiryPutsCallsP/C

Nov 2016d1,471−7%42,7360%0.03

Dec 1844d4800%3,725+1%0.13

Jan 1572d61,0560%17,1570%3.56

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±31.0%

Funds 4

XBI±0.0%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

Q2 FY24 · per later filing

−1538.35%Q2 FY24 · per later filingnet margin

Revenue$850,000—

Gross profit$850,000100.00%—

Operating income−$15M−1770.00%−17.82%

Pre-tax income−$13M−21.22%

Net income−$13M−1538.35%−21.22%

Cost of revenue$0—

Operating expenses$16M+24.47%

Other income$2M−0.71%

Source: SEC filings · standardized · QE Jun 30 '24 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 3 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

FOMC ×1.10· ±4.3% vs ±3.9% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±4.3%7 of 24×1.10

PPIproducer prices±4.1%5 of 10×1.04

CPIconsumer prices±3.7%5 of 10×0.95

CPROFcorporate profits±3.2%7 of 12×0.83

NFPjobs report±3.2%6 of 10×0.82

PCEpersonal income & outlays±3.1%7 of 19×0.80

GDPgross domestic product±3.0%8 of 19×0.76

Bar = avg |move| to ±5% · tick = ±3.9% avg day · ×base = |move| ÷ ±3.9% · min 6 releases

Earnings history

EPS -0.13 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	-0.13	—
Q1 FY26	Mar 5 '26 · confirmed	-0.10	—
Q3 FY25	Nov 5 '25 · confirmed	-0.08	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod